hotspot -WSS

hotspot

author：comprehensive 2025-10-02 20:48:50 - browse：65

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： ActiGraph execs on goal of drug approvals with digital endpoints

Wikipedia

WSS

As Taiwan prepares for anti

CDC backtracks, saying fully vaccinated people can go maskless indoors

Review: 'Barbie' will hit you like a shot in the heart

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

In new study, freeze

focus

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Congress must give Medicare recipients genetic counseling access

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AbbVie dramatically boosts its spending on lobbying

Drug repurposing or repositioning? The language matters

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Jerome Adams on the need for new antivirals for Covid

Trump's false claims about Georgia's 2020 election long debunked

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Clinical trials must include more disabled people

focus

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

What to know about Saharan dust affecting the US and how it can affect health

Clinical trials must include more disabled people

Caitlin Bernard's story shows physicians can't shy from advocacy

ActiGraph execs on goal of drug approvals with digital endpoints

explore

hotspot

Wikipedia

focus